Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins

Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.

Read it at Medical Xpress ↗

← Front page